Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Revisto is a pioneer AI-powered technology that simplifies the medical, legal, and regulatory review process for life sciences marketing.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Sunbird Bio is a diagnostics platform developer that aims to give molecular diagnostics with faster outcomes.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
Basys.ai automates the process of prior authorization and utilization management for health plans/payers using an AI-based platform.
NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick’s Medical School.
OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer’s Disease pathology.
Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.
Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.
Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.
Mariana Oncology is a biotechnology research industry.
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits.
AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.
Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.
Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.
DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.
IgGenix is a biotechnology company.
Eli Lilly has invested in 158 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eli Lilly's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Therapeutics. The firm invests across 21 different industry categories.
Among tracked funding rounds, Aktis Oncology received $175.0M in a Series B round. Eli Lilly's total known invested capital is $7.3B.
Eli Lilly's average investment size is $55.2M across its portfolio of 158 companies.
Recent Eli Lilly portfolio additions include Revisto, Beta Bionics, Sunbird Bio, Aktis Oncology, basys.ai. These companies were founded in 2020 or later.